RSS   Newsletter   Contact   Advertise with us
Post Online Media

Bellicum Pharmaceuticals names Rick Fair as CEO

BellicumBellicum Pharmaceuticals, a clinical stage biopharmaceutical company, announced the appointment of Rick Fair as president and chief executive officer, and as a member of the board of directors.

Mr. Fair joins Bellicum from Genentech/Roche, where he was Senior Vice President, Head of Oncology Global Product Strategy.

Previously, Mr. Fair held several commercial leadership positions within Genentech, including franchise leadership with P&L responsibility for its thrombolytics and oral oncolytics businesses.

Prior to Genentech, he spent nine years in the pharmaceutical business at Johnson & Johnson, holding leadership roles in marketing, managed care and reimbursement strategy, and managed care customer management.

Mr. Fair holds a Bachelor of Science from the University of Michigan, and a Masters of Business Administration from Columbia Business School.


More inside POST

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy